Plenary Session: How to Bridge the GAP - Innovators' experience

Wednesday, June 2


About Arjan van Manen | Executive Vice President, Business and Commercial Development

Arjan van Manen
, has more than 15 years experience in pharma, medical devices and diagnostic with primary expertise in oncology and hematology. International track record in clinical research, international marketing strategy, market access, commercial excellence programs and business development. Worked previously at Takeda Pharma, Bristol-Myers Squibb and Sanofi in commercial and managing positions. He is currently responsible for the Business and Commercial Development at SkylineDx. SkylineDx is an R&D-focused diagnostics company that develops biomarkers. Besides diagnostic test development, our role is also to prepare and execute the clinical roadmap in order to build the value dossier that we can submit for guideline inclusion and market authorization. 




About SkylineDx

SkylineDx is a biotechnology company, focused on research & development of molecular diagnostics in oncology and inflammatory diseases. The company is headquartered in Rotterdam (the Netherlands) and complemented with a field medical and scientific affairs team in the US and a CAP/CLIA certified laboratory in San Diego (California). SkylineDx uses its expertise to bridge the gap between academically discovered gene expression signatures and commercially available diagnostic products with high clinical utility, assisting healthcare professionals in accurately determining the type or status of disease or predict a patient’s response to treatment. Based on test results, healthcare professionals can tailor the treatment approach to the individual patient. To learn more, please visit www.skylinedx.com.  

Powered by:
Hyphen Projects   

    Connect with us                  

Join GAINH

Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
         
 
 
                                    

Register
© Copyright 2020 by Hyphen Projects